RealTime SARS-CoV-2
Device
Abbott Laboratories
Total Payments
$1.1M
Transactions
89
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $718,197 | 20 | 0 |
| 2020 | $345,304 | 69 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.1M | 89 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Abbott RealTime SARS-CoV-2 Specimen Collection Protocol | Abbott Laboratories | $733,197 | 0 |
| Abbott RealTime SARS-CoV-2 Reproducibility and Clinical Testing Study | Abbott Laboratories | $294,480 | 0 |
| RealTime SARS CoV-2 assay evaluation of saliva sample type | Abbott Laboratories | $35,824 | 0 |
Top Doctors Receiving Payments for RealTime SARS-CoV-2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Clearwater, FL | $1.1M | 89 |
Ad
Manufacturing Companies
- Abbott Laboratories $1.1M
Product Information
- Type Device
- Total Payments $1.1M
- Total Doctors 0
- Transactions 89
About RealTime SARS-CoV-2
RealTime SARS-CoV-2 is a device associated with $1.1M in payments to 0 healthcare providers, recorded across 89 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2020 to 2021. In 2021, $718,197 was paid across 20 transactions to 0 doctors.
The most common payment nature for RealTime SARS-CoV-2 is "Unspecified" ($1.1M, 100.0% of total).
RealTime SARS-CoV-2 is associated with 3 research studies, including "Abbott RealTime SARS-CoV-2 Specimen Collection Protocol" ($733,197).